Your browser doesn't support javascript.
loading
Switchable Cas9.
Richter, Florian; Fonfara, Ines; Gelfert, Renate; Nack, Jennifer; Charpentier, Emmanuelle; Möglich, Andreas.
Afiliação
  • Richter F; Bayer AG, Pharmaceuticals, Protein Engineering and Assays, 50829 Köln, Germany. Electronic address: florian.richter@bayer.com.
  • Fonfara I; Max Planck Institute for Infection Biology, 10117 Berlin, Germany; The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Centre for Microbial Research (UCMR), Department of Molecular Biology, Umeå University, Umeå 90187, Sweden. Electronic address: fonfara@mpiib-berlin.mpg.de.
  • Gelfert R; Universität Bayreuth, Lehrstuhl für Biochemie, Bayreuth, Germany.
  • Nack J; Universität Bayreuth, Lehrstuhl für Biochemie, Bayreuth, Germany.
  • Charpentier E; Max Planck Institute for Infection Biology, 10117 Berlin, Germany; The Laboratory for Molecular Infection Medicine Sweden (MIMS), Umeå Centre for Microbial Research (UCMR), Department of Molecular Biology, Umeå University, Umeå 90187, Sweden.
  • Möglich A; Universität Bayreuth, Lehrstuhl für Biochemie, Bayreuth, Germany; Universität Bayreuth, Research Center for Bio-Macromolecules, Bayreuth, Germany.
Curr Opin Biotechnol ; 48: 119-126, 2017 12.
Article em En | MEDLINE | ID: mdl-28456061
ABSTRACT
Ever since its discovery, Cas9 from Streptococcus pyogenes has revolutionized biology by enabling analysis and engineering of genomes with unprecedented precision and ease. To fine-tune on-target effects and to mitigate adverse effects caused by untimely and off-target action of Cas9, strategies have been developed to control its activity at the post-translational stage via external trigger signals. Control is either achieved by modifying the Cas9 protein itself or its programmable RNA molecules. To date, switchable Cas9 variants responding to small ligands, light or temperature have been engineered. With these variants in hand, the regulation and modification of genomes can be accomplished in graded and ever more precise manner.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Engenharia Genética / Genoma Humano / Regulação da Expressão Gênica / Proteínas Associadas a CRISPR / Sistemas CRISPR-Cas Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Engenharia Genética / Genoma Humano / Regulação da Expressão Gênica / Proteínas Associadas a CRISPR / Sistemas CRISPR-Cas Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article